Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients

Active, not recruitingOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

June 28, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Critical IllnessAcute Kidney InjurySepsisSystemic Inflammatory Response Syndrome
Interventions
DEVICE

oXiris

Every center will prescribe EBPT with oXiris in accordance with local practice and local levels of expertise. No variation in treatment prescription and/or treatment solutions will derive from participation in this prospective observational study. Nonetheless, every setting parameter will be recorded in the web-based registry and analyzed a-posteriori to reveal a potential correlation with the patient outcomes.

Trial Locations (12)

20097

IRCCS Policlinico S. Donato Milanese, San Donato Milanese

25040

Presidio Ospedaliero di Esine, Esine

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

50053

S. Giuseppe Hospital, Empoli

50100

Azienda Ospedaliero Universitaria Careggi, Florence

51100

Ospedale San Jacopo, Pistoia

80138

"A.O.U. della Campania L. Vanvitelli", Napoli

82100

Ospedale Sacro Cuore di Gesù-Fatebenefratelli, Benevento

06129

Ospedale S. Maria della Misericordia, Perugia

00149

S.Camillo Forlanini Hospital, Roma

00167

Cristo Re Hospital, Roma

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
collaborator

University of Florence

OTHER

lead

Careggi Hospital

OTHER